The time has come for repealing Medicaid’s Institutions for Mental Diseases Exclusion rule.
The court ruling striking down the Affordable Care Act may get in the way of making drugs affordable.
Although “Medicare for all” has picked up political traction, how it will materialize remains unclear.
Experts offer solutions to pressing issues in American health care.
Scholars say constitutionally shaky infectious disease regulations must yield to better prevention programs.
A federal judge strikes a blow to two states’ Medicaid work requirements.
Scholar argues that FDA should use a narrowly tailored framework to regulate encapsulated placenta pills.
Plant-based milk producers may soon no longer be able to put “milk” on their labels.
Scholar argues FDA should regulate insects as food to help address food insecurity.
National injunction stops corporations from claiming religious or moral exemptions to birth control coverage.
Scholars argue that FDA should use larger health data sets in its approval process for high-risk drugs.
Expert argues for altering regulations on psychedelic drugs to treat mental illness and addiction.